ArticleClinical journal of the American Society of Nephrology : CJASN2017
Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.
Article in Clinical journal of the American Society of Nephrology : CJASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Iodine-based contrast media in contrast-enhanced mammography and dedicated breast computed tomography: is it necessary to assess renal function in all outpatients to prevent contrast-induced acute kidney injury?European radiology · 2024Article
- Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation.Journal of clinical medicine · 2024Article
- The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience.Breast cancer (Tokyo, Japan) · 2024Article
- A Global Survey of Self-Reported Cancer Screening Practices by Health Professionals for Kidney Transplant Candidates and Recipients.Transplant international : official journal of the European Society for Organ Transplantation · 2024Article
- Prior cancer history and suitability for kidney transplantation.Clinical kidney journal · 2023Review
- Temporal changes and risk factors for death from early withdrawal within 12 months of dialysis initiation-a cohort study.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022Article
- Review
- Emerging Concepts in Managing Malignancy in Kidney Transplant Patients.Seminars in nephrology · 2022Review
- Incidence and Outcomes of Early Cancers After Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2022Article
- Perspectives From an Onconephrology Interest Group: Conference Report.Canadian journal of kidney health and disease · 2020Article
- Cancer in kidney transplant recipients.Nature reviews. Nephrology · 2018Review
- Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
BACKGROUND AND
objectivesBreast and cervical cancers are prevalent in women with CKD, but it is uncertain how often screening for these cancers should be undertaken given concerns that the benefits of screening may be fewer and the harms greater in women with CKD than in the general population. We examined patterns of breast and cervical cancer screening in women on the basis of CKD stage and age and assessed predictors of screening. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted two population-based cohort studies (breast and cervical cancer screening) from 2002 to 2013 using linked administrative health care data from Ontario, Canada. A total of 141,326 and 324,548 women were included in the breast and cervical cancer screening cohorts, respectively.
resultsThe 2-year cumulative incidences were 61% among women without CKD, 54% for those with CKD stages 3a and 3b, 37% for those with CKD stages 4 and 5, and 26% for women on dialysis. Similar patterns were observed for the 3-year cumulative incidences of cervical cancer screening. The associations of breast and cervical cancer screening with CKD were modified by age and CKD stage, where lower incidence of screening in women with advanced CKD compared with no CKD was most pronounced in older age groups (P<0.001). Older age, higher comorbidity burden, and lower-income groups were associated with a lower rate of screening.
conclusionsMost women with advanced CKD do not receive breast or cervical cancer screening. A better understanding of patient and health professional preferences toward cancer screening in CKD is needed along with the outcomes of such screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.